A young, dedicated inventor-operator; a dedicated surgeon who has spent a career on the problem; an executive who has built and financed device companies before; and a composites engineer who spent 35 years making structures that do not fail.
Co-Founder & Chief Executive Officer
Philip began developing LunaFlex in 2015 and co-founded Caeruleum in 2022 after graduating from Fordham University. He has spent more than a third of his life building the company, deliberately shaping his academic and professional path to prepare for his role leading Caeruleum.
MAIN LINE HEALTH NETWORK · NEWMARK GROUP · SKIFTE VENTURES
Co-Founder & Chief Medical Officer
Lawrence is an orthopaedic surgeon with more than 35 years of clinical leadership and decades of experience in meniscal transplantation. He founded and chaired Cooper University Hospital’s Department of Orthopaedic Surgery and directed its Bone and Joint Institute through 2022.
Cooper University Hospital of Rowan University · Lankenau Medical Center · Kerlan-Jobe Institute
Executive Chairman
Matthew brings 40 years of biopharmaceutical leadership to Caeruleum. A founding partner of Egret Healthcare Ventures, he helped form four new device companies. He founded Tactiva Therapeutics, led its $35M Series A, and was an early commercial and management hire at Genentech.
Egret Healthcare Ventures · Tactiva Therapeutics · Genentech · Pharmacia · Neurex · Insmed
Senior Materials Engineer
Philip spent 35 years at Boeing as an Associate Technical Fellow, leading work on aircraft structures designed for decades of repeated loading. He holds three utility patents in composite processing and qualified fabrication vendors worldwide to Boeing’s demanding specifications.
The Boeing Company Helicopter Division · The De Havilland Aircraft Company
Founder spotlight
An inventor’s long-term commitment to the design, paired with decades of orthopaedic and institutional leadership.
Co-Founder & Chief Executive Officer
Philip is the sole inventor of U.S. Patent No. 11,147,677, which covers the fiber-reinforced artificial meniscus at the center of the LunaFlex platform. He began developing LunaFlex in 2015 through a science-fair project for the Pennsylvania Junior Academy of Sciences (PJAS) and has continued the work ever since. Before Caeruleum, Philip worked across financial planning and modeling, corporate strategy and research, and investor relations. As a consultant to Newmark Group, he worked with senior leadership on growth initiatives and led the planning and execution of the Knotel Communities co-working product launch. He now leads Caeruleum’s corporate strategy, finance, and investor relations.
Co-Founder & Chief Medical Officer
Dr. Miller brings more than three decades of orthopaedic, sports-medicine, and institutional leadership to the LunaFlex program. After completing a Sports Medicine Fellowship at the Kerlan-Jobe Institute in 1985, he served on the core faculty at Thomas Jefferson University Hospital and later co-directed its Sports Medicine Fellowship Program. At Lankenau Medical Center, he was Academic Service Chief and Chief of the Division of Orthopaedic Surgery. He joined Cooper University Hospital in 2002, serving first as Division Head and then as the founding Chief and Chairman of Orthopaedic Surgery through 2022. He also directed Cooper’s Bone and Joint Institute from 2002 to 2022. Dr. Miller received the Philadelphia Sports Medicine Congress Torg Award in 2008 and became a founding member of the MERCuRE Group in 2019. At Caeruleum, he helps connect product development with clinical practice and surgical decision-making.
